Clinical Perspective: Advancing Hemophilia Treatment through Gene Therapy Approaches

Three primary gene therapy approaches at the forefront of clinical development are reviewed. Adeno-associated virus-based gene therapy, having secured approval in the EU, UK, and USA after promising Phase III trial results, demonstrates clear superiority over standard-of-care treatment.